Reply to the editor

J Thorac Cardiovasc Surg. 2013 Feb;145(2):610-1. doi: 10.1016/j.jtcvs.2012.11.003.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antifibrinolytic Agents / adverse effects*
  • Aprotinin / adverse effects*
  • Blood Loss, Surgical / prevention & control*
  • Humans
  • Postoperative Hemorrhage / prevention & control*

Substances

  • Antifibrinolytic Agents
  • Aprotinin